Resistance mechanisms also remain a significant barrier, with primary resistance often due to a lack of CD8+ T-cell recognition or localization to the tumor, as well as acquired resistance from impaired antigen presentation and loss of T-cell function. The gene discussed is CD8A; the disease is neoplasm.